Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of 7459.T is 2632 and suggests 11% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell